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Potential benefits and hazards associated with the use 
of e-cigarettes — a guide for practitioners and current 
status in Poland 
Abstract
The use of electronic cigarettes has dynamically increased over the last few years. Meanwhile, the knowledge regarding their 
safety has been rapidly changing, which could be a challenge for a medical practitioner. The purpose of this review is to summarize 
the latest reports and to verify statements on e-cigarettes’ influence on health, including in the context of the ongoing SARS-CoV-2 
pandemic. Awareness of the benefits of e-cigarettes can provide vital support for doctors caring for patients who smoke tra-
ditional cigarettes. Nevertheless, attention should be paid to the dangers of the medically unjustified use of electronic cigarettes.
Despite the idea of releasing e-cigarettes into the market as a harmless alternative to traditional cigarettes, this product also has 
a negative impact on health. Replacing traditional cigarettes with e-cigarettes provides well-documented benefits to patients 
with certain indications such as hypertension and asthma, as well as to smokers who intend to minimize the negative effects 
of passive smoking on their environment. Moreover, it could be valuable for patients who are willing to permanently overcome 
a nicotine addiction, especially when previous attempts to quit smoking with nicotine replacement therapy (NRT) monotherapy 
were unsuccessful. Electronic cigarettes are a rapidly developing technology and an innovative form of a well-known addiction, 
so it is essential for practitioners to stay informed.
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Introduction
The popularity of e-cigarettes worldwide has 
considerably increased over the last few years. It 
is claimed that they are consistently used by 1,4% 
of the Polish population aged 15 and older, and 4% 
declare having used them at least once [1]. From 
2014 to 2017, a 20% increase in their use had been 
noted in the European Union. Currently, it involves 
almost 2% of Europeans [2]. Numerous myths have 
existed in the public sphere and the confidence in 
their authenticity is the reason why the popularity 
of the phenomenon called vaping is growing. In 
Poland, aside from being a fashionable trend, the 
primary reasons for using e-cigarettes include them 
being a healthier alternative to smoking, the belief 
in their efficacy in overcoming nicotine addiction, 
and saving money [3]. Foreign studies confirm 
that the most common excuse for the initiation 
of e-cigarette usage is a conviction about their 
beneficial effects on smoking cessation and on the 
environment [4]. The increase in e-cigarette use is 
particularly high among young people [5].
An electronic cigarette is a small, battery-po-
wered device filled with liquid containing nicoti-
ne. It gives an impression of traditional cigarette 
smoking [6]. The Polish legal definition describes 
an e-cigarette as a “product which is used for the 
consumption of vapour containing nicotine by 
using a mouthpiece […]; e-cigarettes may be of 
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single-use or can be refillable […]” [7]. Currently, 
an e-cigarette resembles a thick pen made of two 
parts: a source of power, hence a battery, and 
a vaporizer with a container filled with fluid, 
which contains nicotine in various concentrations 
and flavours, as well as typically glycerine and 
propylene glycol. Nicotine consumption is based 
on inhaling steam produced as a consequence of 
boiling this liquid. Such a process does not pro-
duce smoke, which is associated with traditional 
cigarettes.
In Poland, the addiction to e-cigarettes has 
expanded specifically among the younger genera-
tion — 60% of middle school students admit using 
both traditional and electronic cigarettes, another 
10% declare the use of just e-cigarettes, and 11% 
of teenagers who have not tried traditional ones 
tried an electronic cigarette during the last thirty 
days (an increase of over 1/3 as compared to the 
time period between 2014–2017). Subsequently, 
the percentage of people who regularly vape has 
risen three times over — up to 6%. Generally, the 
proportion of people who have used e-cigarettes 
exclusively during the last thirty days has grown 
fivefold from 2% in 2010–2011 to 11% in 2015-
2016. As high as 24% of interviewed individuals 
confirm the consumption of both electronic and 
traditional cigarettes over the last thirty days. It 
represents a sixfold increase from 4% in 2010–
2011 to 24% in 2015–2016 (p < 0.05) [5].
Even though the percentage of smokers has 
slightly decreased in our country (from 24% in 
2017 to 21% in 2019 with a statistically unva-
rying difference between men and women), the 
number of people reaching for e-cigarettes has 
grown, especially among young people living in 
cities with more than 100,000 inhabitants [1, 3]. 
Taking into account the expansion of e-cigarette 
use in Poland, the aim of this review is to elabo-
rately summarize the current state of knowledge 
concerning their potential benefits and hazards.
Influence on the respiratory system
Traditional cigarettes have been proven to 
have significant adverse effects on the respiratory 
system and are the main cause of lung cancer and 
chronic obstructive pulmonary disease (COPD) 
[8]. This toxic influence is derived from the occu-
rrence of many hazardous substances in tobacco 
smoke. Studies showed that they initiate the in-
flammatory process resulting in the development 
and progress of COPD and lung cancer [9, 10]. In 
recent years, the morbidity and mortality from 
COPD has notably increased [11]. According to 
the estimated data, 2 million people in Poland 
suffer from this disease and 15 thousand die from 
its complications every year. It is well-known 
that adults who smoke traditional cigarettes have 
a 61% greater risk of developing asthma, and 
a 1.71 times greater risk of exacerbations of asth-
ma in comparison to non-smokers (p < 0.05) [12]. 
Furthermore, it is confirmed that children who are 
subject to passive smoking have a 20% greater risk 
of developing asthma. The need to utilize corti-
costeroids for asthma exacerbations increases by 
1.71 (p = 0.004) [13, 14]. Additionally, the fetal 
exposure to tobacco smoke is associated with lung 
underdevelopment and other minor dysfunctions 
which lead to obstructed air flow later in life [15].
The presence of many toxic substances in 
tobacco smoke has not been confirmed in e-ciga-
rette vapour. However, flavour extracts present in 
e-cigarettes may expose their users to health risks 
[16]. Moreover, according to research where the 
influence of 5-minute usage of an e-cigarette on 
lung function was tested among healthy adults, 
it was found that even short-term vaping causes 
immediate serious adverse effects similar to tra-
ditional cigarette smoking [17].
Multiple sweet aromas were tested with 
the aim of searching for toxic chemical sub-
stances. The findings have shown that most of 
the samples contained diacetyl, the presence 
of which was associated with the occurrence of 
bronchiolitis obliterans, also called “popcorn 
lung” [16, 18]. Importantly, the in vivo study has 
demonstrated the inefficiency of cellular prote-
ase as a consequence of aerosol exposure, which 
suggests the potential role that e-cigarettes may 
have in the pathogenesis of emphysema in COPD 
[19]. Additionally, there is a 39% greater risk of 
developing asthma among current e-cigarette 
users as compared to people who have never used 
them. At the same time, the increased intensity of 
usage was observed to be associated with an in-
creased probability of asthma development [20]. 
On the other hand, the substitution of traditional 
cigarettes for electronic cigarettes among people 
already diagnosed with asthma was observed to 
be associated with long-term benefits such as al-
leviation of symptoms and better asthma control 
with a reduction in the number of exacerbations 
[21]. Nonetheless, one of the e-liquid ingredients, 
propylene glycol, may worsen both asthma and 
COPD despite being relatively non-toxic [22].
In July of 2019, the Wisconsin Department 
of Health Services and the Illinois Department of 
Public Health received many notifications about 
lung injuries associated with e-cigarette usage 
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(EVALI, e-cigarette, or vaping, product use-as-
sociated lung injury), which started coordinated 
research projects in order to establish the exact 
cause of this pathology. On the 6th of September 
2019, there were 98 patients who matched the 
definition of probable or confirmed cases of 
EVALI. The average age was 21. The chief repor-
ted complaints involving the respiratory system 
(especially shortness of breath, cough, and chest 
pain) as well as the digestive system (particularly 
nausea, vomiting, diarrhea, and abdominal pain). 
Among 81 extensively interviewed patients, 73% 
of them admitted using nicotine products and 
89% of the products contained tetrahydrocanna-
binol, the basic psychoactive substance in canna-
bis [23]. According to another study from 2019, 
e-cigarettes were associated with a wide variety 
of lung diseases, primarily acute eosinophilic 
pneumonia, diffuse alveolar damage, and lipoid 
pneumonia. Presumably, the contributory factor 
in these pathological entities is tocopheryl aceta-
te, also known as vitamin E acetate, an additive 
in e-liquids with tetrahydrocannabinol [24]. The 
analysis of the bronchoalveolar lavage led to the 
detection of vitamin E acetate in the epithelial 
lining fluid (ELF) among 48 of 51 patients with 
EVALI and, concurrently, the absence of this ester 
was confirmed in the healthy controls [25]. By the 
18th of February 2020, the CDC had 2,807 repor-
ted cases of hospitalized or dead EVALI patients 
[26]. It should be emphasized that, in European 
Union countries where THC is forbidden, EVALI 
was not observed [27].
Influence on the circulatory system
The detrimental effect of traditional cigarette 
smoking on the cardiovascular system has been 
thoroughly acknowledged and described. Its asso-
ciation with coronary artery disease, myocardial 
infarction, arteriosclerosis, aortic aneurysm for-
mation, and peripheral arterial disease has been 
proven. The harmful outcome of passive smoking 
was also confirmed [28]. Furthermore, studies 
on monozygotic twins where only one of them 
was a traditional cigarette smoker revealed that 
a smoking sibling had the median plasma renin 
activity 99% greater at rest and 84% greater during 
a submaximal exercise as compared to the other 
twin (p < 0.01). Additionally, during exercise, 
the smokers had the median level of aldosterone 
generally 40% greater than their nonsmoking 
siblings (p < 0.05). This phenomenon partly 
explains the tendency for vasoconstriction to 
occur in traditional smokers [29].
Considering the above, adverse effects of 
traditional cigarettes may be divided into tho-
se resulting from nicotine toxicity and those 
associated with other chemical substances and 
physical factors. Nicotine acts as sympathomi-
metic, thus it increases myocardial oxygen de-
mand [30]. Moreover, it was shown that in rats 
with primary hypertension, it augments a risk of 
developing hypertrophic cardiomyopathy [31]. 
Another toxic substance present in tobacco smo-
ke is carbon monoxide (CO), which binds with 
hemoglobin thus reducing the oxygen-binding 
capacity of blood. As a consequence, it leads to 
hypoxemia, overproduction of erythrocytes, and 
hypercoagulability [32]. The correlation between 
smoking and raised inflammatory markers was 
also proven [33]. The chemical composition of 
classic cigarettes was examined providing in-
formation about the presence of heavy metals in 
tobacco smoke – particularly manganese, nickel, 
and chrome [34]. These metals catalyze protein 
oxidation in epithelial cells, resulting in their 
malfunction [35]. In addition, the cobalt concen-
tration in the aorta correlates with the number 
of smoked pack-years, which increase the risk of 
aortic aneurysm formation [36]. As a consequ-
ence of the above factors, the risk of developing 
cardiovascular disease increases.
Hazardous substances discovered in e-ci-
garette vapour include nicotine and heavy me-
tals. However, it seems that the concentration 
of heavy metals in aerosols does not appear to 
be at toxic levels and is certainly lower than the 
concentration in traditional cigarette smoke [37]. 
In turn, the amount of nicotine and its resulting 
toxicity varies due to different liquids used in 
different types of these devices ranging from 
nicotine-free cartridges to ones with a nicotine 
content higher than in classic cigarettes [38].
It was proven that e-cigarettes elevate both 
the systolic and diastolic blood pressure and 
increase the heart rate, but to a much lesser 
degree than traditional smoking. Furthermore, 
e-cigarettes have no influence on the amount of 
exhaled carbon monoxide, which is in marked 
contrast to classic cigarette smoke (eight times 
greater than the baseline) [39]. Among smokers 
treated for hypertension, e-cigarettes facilitated 
a reduction in systolic and diastolic blood pres-
sure. This effect was long-lasting and was seen 
early in the course of treatment when smokers 
of classic cigarettes were beginning to use e-cig-
arettes, which at the same time limited the use of 
the classic ones [40]. A prospective study based 
on healthy young individuals aged 29.7 (± 6.1) 
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did not show a negative impact of e-cigarettes 
on the circulatory system (respiratory rate [RR], 
systolic and diastolic blood pressure [SBP and 
DBP]) after 3.5 years of vaping. Presumably, we 
should wait longer to observe the adverse effects 
of aerosol exposure. Currently, long-term studies 
of this kind are not available [41].
Influence on carcinogenesis
The inhaled smoke from classic cigarettes is 
recognized as the main cause of neoplasia [28]. 
Multiple substances present within this smoke qu-
alify as carcinogenic substances according to the 
International Agency for Research on Cancer [42]. 
Considering the influence of e-cigarettes on 
the development of oncologic conditions, there 
are only a few studies which have been conduc-
ted in the recent past. Currently, there is no clear 
evidence-based affirmation of the carcinogenic 
role of vaporizers. The majority of conclusions 
are based on studies involving animal and cell 
cultures [43].
In its 2018 report, the American National 
Academy of Sciences, Engineering and Medi-
cine (NASEM) informed about the influence of 
e-cigarettes on public health, including the risk 
of carcinogenesis. The report states that the only 
correct conclusion which can be made from the 
up-to-date research is the confirmation of the pre-
sence of mutagens in e-cigarettes’ aerosol. Indeed, 
these substances are proven, both in vitro and 
in vivo, to damage DNA. In high concentrations, 
they have also been proven to damage human 
DNA, yet they cannot be explicitly connected 
with the possibility of carcinogenesis among ac-
tive e-cigarette users. Further research is required 
to clarify if the concentration of these mutagens in 
the inhaled aerosol is sufficient enough to initiate 
mutagenesis. However, there is limited existing 
evidence showing increased carcinogenesis in 
animal models secondary to long-term exposure 
to e-cigarette vapour [44].
Since the publication of the NASEM report, 
new studies have suggested the possibility of the 
causal association between e-cigarettes and the 
development of cancer. For instance, mice which 
were exposed to this aerosol for 54 weeks had 
a significant tendency to develop lung adeno-
carcinoma (22,5% out of 40 animals involved in 
this experiment) as well as urothelial hyperplasia 
of the bladder (57,5% out of 40). In the control 
group, there was only one mouse out of 40 which 
developed lung cancer [45]. In another research 
article, experimental mice were implanted with 
breast cancer cells. The prevalence of tumor pro-
gression was horrific. 100% of the animals which 
had been previously exposed to e-cigarette aerosol 
developed cancer, compared to 33% in the control 
group which had only been breathing room air. 
Moreover, this progression was evidently faster in 
the exposure group than in the control group. Lung 
metastases were also significantly more frequent 
among rodents from the exposure group. The same 
research clearly confirmed the increase of the 
capability of pathologic cells to escape apoptosis 
after exposure to e-cigarette vapor [46]. Based on 
these observations, it was assumed that vaping was 
associated with tumor progression as well as with 
a limitation of the immune response, which ena-
bled destruction of cancer cells shortly after their 
implantation. Another study validated an increase 
in the degree of DNA degradation and a decrease 
in its repair activity in mice lungs, hearts, and 
bladders, as well as in cell cultures obtained from 
human lung and bladder cells (p < 0.05) [47].
There are only a few studies on the subject 
of the health hazards of passive e-cigarette smo-
king. Even though there are significantly lower 
concentrations of toxic substances in the aerosol 
than in tobacco smoke, they can potentially lead 
to serious consequences, especially when vaping 
takes place in a limited, enclosed space, and when 
there is a high concentration of vapour. Passive 
smoking may possibly result in irritation of the 
airways from inhaling glycerol and propylene 
glycol vapour. The effects of nicotine aspiration 
(activation of the sympathetic nervous system, 
increased blood pressure, and tachycardia) as 
well as the potentially mutagenic activity of 
tobacco-specific nitrosamines should also be 
taken into consideration, although they are not 
currently included in most of the liquids [48]. It 
seems that the use of e-cigarettes in closed spaces 
does not endanger passive smokers by noxious 
concentrations of toxic substances. However, 
the influence of nicotine may be perceptible and 
potentially adverse [49]. No evidence has been 
found pointing to increased carcinogenic risk or 
the absence of such a risk in individuals exposed 
to passive electronic cigarette smoking. The only 
undeniable fact is that smokers are subject to 
a lower concentration of toxic substances while 
using electronic devices rather than traditional 
cigarettes [44].
Influence on the oral cavity
There are two main dental problems related 
to tobacco smoke exposure: tooth decay and 
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influence of NRT on birth weight is still unclear. 
The findings are actually contradictory [64, 65].
Studies conducted on animal models ap-
pear to be more suggestive yet still insufficient. 
They showed normal birth weight of offspring of 
mothers who were exposed to e-cigarette vapour. 
However, their subsequent growth was stunted 
as opposed to individuals born in a control group 
[60]. Additionally, studies which were performed 
on rats reported that rodents previously exposed 
to vaping delivered low birth weight offspring in 
contrast to rats from the control group, and this 
difference was statistically significant. The same 
research also presented a distinct decrease of blo-
od flow in the uterine artery (49.5%) and in the 
umbilical artery (65.3%) among the experimental 
group versus the comparison group (p < 0.05) [66].
Difference in the cost of smoking traditional 
cigarettes and vaping
It is still a challenge to formulate a precise 
analysis about costs borne by people smoking 
classic cigarettes as opposed to e-cigarette users. It 
comes from the fact that there is a great diversity 
between prices of traditional cigarettes and a wide 
range of prices of electronic cigarettes. The compa-
rative analysis from 2017, performed on the basis 
of estimated data collected from 45 countries com-
paring the prices of equal units of nicotine, showed 
that traditional cigarettes are generally cheaper than 
single-use e-cigarettes. In the USA, this difference 
was $6.82 vs $7.99. In Poland, the difference was 
$4.18 vs $4.76. On the other hand, the price of liquid 
refills used in multiple-use e-cigarettes may be lo-
wer than classic cigarette packs, although the initial 
purchase of multiple-use electronic cigarettes poses 
a definitive financial burden on people exchanging 
smoking for vaping. After proper review of prices 
of traditional cigarettes and electronic multiple-use 
devices, the authors of this analysis estimated the 
time needed to recover the initial expense of swi-
tching to e-cigarettes for each country. In Poland, 
this amounted to a total of 6 days [67]. Nevertheless, 
it should also be emphasized that on the 1st of July 
2020, a new tax was implemented on e-cigarettes 
in Poland which may result in a change in the cal-
culations described above. 
Dual use of nicotine products
The introduction of e-cigarettes is associated 
with a certain risk of simultaneous use with tradi-
tional cigarettes, which constitutes a phenomenon 
known as dual smoking (i.e. dual users). During 
three time periods (2010–2011, 2013–2014, and 
2015–2016), with the aid of an anonymous ques-
tionnaire intended for upper-secondary students 
and technical school students in Poland (n = 
5708), data was collected regarding current and 
previous tobacco smoking and e-cigarette use. 
45% of the respondents confirmed a dual supply 
of nicotine in the past, and 17% of them admitted 
to dual use during the 30 days preceding the filling 
out of the questionnaire [5]. According to a Pol-
ish nationwide cross-sectional study from 2019, 
28.6% of people declaring e-cigarette usage were 
also smoking traditional cigarettes on a daily basis 
[1]. It is a common phenomenon and every vape 
enthusiast is potentially subjected to a growing 
tendency towards additional exposure to tobacco 
smoke. Data from surveys gathered in the USA 
also confirmed this foregoing regularity — 31.8% 
of former users and 34.6% of current e-cigarette 
users (during the last 30 days) answered affirma-
tively to the question about any additional classic 
cigarette smoking [68]. Importantly, it was proven 
that teenagers using exclusively electronic ciga-
rettes displayed a stronger tendency towards the 
new onset of traditional smoking during a 5 year 
follow-up in comparison to non-users of these 
devices [69]. However, it should be stressed that 
this statement is only correct with regards to 
e-cigarette users without a documented strong nic-
otine addiction. In fact, people with an advanced 
addiction to nicotine who have been consistently 
using e-cigarettes are less prone to simultaneous 
traditional cigarette smoking [70].
The addiction to classic cigarettes and e-ciga-
rettes was analyzed in the research conducted in 
2018 on a group of dual smokers using specially 
designed psychometric measures. On average, 
stronger addiction to traditional cigarettes was 
reported than to electronic ones. The differences 
in nicotine craving in both methods of delivery 
were documented, which suggests that dual users 
may actually differentiate the degree of addiction 
to each of these products [71]. Another study con-
firmed that e-cigarette users regarded vaping as 
causing less dependence to nicotine. Additionally, 
for people inhaling the aerosol, it was easier to 
restrain themselves from smoking in places where 
it was forbidden. The same group also reported 
a longer time from awakening to the first intake of 
nicotine in comparison to traditional smokers [72].
Combating nicotine addiction
A potential role of e-cigarettes in the process 
of overcoming smoking addiction is not suffi-
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ciently known. In January 2018, The US Surgeon 
General reported various conclusions of differing 
potential. The authors of this report confirm the 
presence of limited evidence for e-cigarette use in 
the process of overcoming the addiction to smo-
king. Statements which suggested a greater effica-
cy of e-cigarettes containing nicotine were actually 
believed to be of moderate strength. Documenta-
tion regarding the advantage of e-cigarette use in 
combating addiction over other methods approved 
by the FDA (i.e. NRT, varenicline, bupropion) 
was found to be insufficient [44]. Nevertheless, 
new and high-quality research conducted shortly 
after the publication of the above report allowed 
for new light to be shone on previously provided 
conclusions. A British study which compared 
the effectiveness of NRT and e-cigarettes based 
on a sizable sample of patients (about 700 people 
in two corresponding size groups which finished 
an annual program) showed that e-cigarette use 
had an eminently better result for the purpose of 
overcoming nicotine dependency. The percentage 
of the annual success rate in a group which used 
traditional replacement therapy was 9.9%, whe-
reas it was almost twice as high in a group using 
e-cigarettes (18%) (p < 0.001). Both types of the-
rapy were assessed as less satisfying than smoking 
cigarettes by patients who took part in research 
studies. However, vaping was graded higher than 
NRT. E-cigarette users reported less irritability 
and fatigue, and a better ability to concentrate 
(relative to the initial stage) than patients receiving 
nicotine replacement therapy. Nausea was also 
less frequent in the vaping group. The NRT profile 
was more preferable in only two subgroups: those 
where there was a general degree of irritation of 
the oral cavity and throat (63.5% vs 51.2%), and 
in those where the irritation was severe (5.9% 
vs 3.9%) [73]. The helpful role of e-cigarettes 
was also noted in a study conducted on a group 
of over 1,100 smokers in which the efficacy of 
three therapies was compared. One of them was 
based on a monotherapy with the use of nicotine 
patches, whereas two others were combination 
therapies based on patches and e-cigarettes with 
nicotine-containing liquid or nicotine-free liquid. 
NRT without the addition of electronic cigarettes 
showed the lowest success rate. The group which 
received traditional replacement therapy had the 
highest percentage of patients who finished the 
participation in the program prematurely. NRT 
supplemented by e-cigarettes with nicotine was 
seen to provide the most effective method of quit-
ting smoking, both during semi-annual and annual 
periods. Depending on the observation’s time 
period, this method was from 3 to 7 percentage 
points more efficacious than the one with nicoti-
ne-free e-cigarettes. According to the authors, the 
optimal therapy was also 5 to 10 percentage points 
more successful than monotherapy with nicotine 
patches (p < 0.05) [74]. 
Yet another study showed that the use of 
e-cigarettes, which are similar in appearance 
to classic cigarettes, may be more successful in 
combating nicotine cravings than the use of devi-
ces which have a different appearance (i.e. most 
e-cigarettes of the newest generation). Despite 
a small sample size (n = 63), this study may pre-
sent a valuable clue to people trying to overcome 
the addiction [75].
The association with COVID-19
The SARS-CoV-2 pandemic requires careful 
and new reflection in the context of the safety pro-
file of e-cigarettes. The research conducted in July 
2020 revealed that both smoking tobacco and va-
ping may increase vulnerability to COVID-19. Ho-
wever, it should be emphasized that e-cigarettes, 
which do not contain nicotine, contribute to the 
development of these changes to a much lesser 
degree than classic cigarettes. In contrast to the 
exposure to e-liquid aerosol, smoking tobacco was 
also proven to increase ACE2 expression — a cell 
receptor with a high-affinity for SARS-CoV-2 [76].
Patients who have a positive history of smo-
king tobacco show a much higher risk of having 
a severe course of the coronavirus disease (CO-
VID-19) (RR: 1.31), in-hospital mortality (RR: 
1.26), subsequent progression of disease (RR: 
2.18), and need for mechanical ventilation (RR: 
1.20) [77]. 
According to an online study conducted in 
May 2020 among teenagers and young adults (n 
= 4351) between the ages of 13 and 24, the diag-
nosis of COVID-19 is five times more probable for 
exclusive e-cigarette users and seven times more 
probable for dual smokers [78]. Moreover, con-
sidering the potential acute toxicity of electronic 
cigarettes involving the lungs and cardiovascular 
system, the use of these products may expose pa-
tients infected with SARS-CoV-2 to a greater risk 
of developing a severe course of COVID-19 [79].
Discussion
The period of over ten years where e-ciga-
rettes have been present on the market have not 
been able to unequivocally prove and/or assess 
long term effects of their use. The intensification 
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of research associated with the increasing use of 
these devices provided strong information which 
should influence the perception of e-cigarette 
use by general practitioners. Based on the above 
review of literature, we would like to carefully 
investigate potential benefits as well as risks as-
sociated with e-cigarette use. 
Vaping as a replacement for smoking classic 
cigarettes is beneficial to patients diagnosed with 
bronchial asthma. The exposure to aerosol rather 
than tobacco smoke contributes to a decrease in 
respiratory system symptom intensity and to an 
improvement in lung function. At the same time, 
it should be emphasized that e-cigarette use pre-
disposes to the development of asthma, although 
the risk of its occurrence seems to be lower than 
that of traditional smokers. A possible decrease 
in the risk of developing COPD is the additional 
advantage — classic cigarettes are the major etio-
pathological factor here, whereas vaping was not 
unequivocally associated with it.
A particular benefit of exchanging traditional 
cigarettes for electronic ones is seen in patients 
suffering from hypertension. In this group, the 
positive change in blood pressure is statistically 
significant and permanent. However, it should be 
noted that any form of nicotine, a sympathomi-
metic, causes temporary elevation of the systolic 
blood pressure. It is particularly important in pa-
tients with poorly controlled hypertension. In this 
case, the use of liquids with low nicotine content 
might be preferable. Additionally, a significantly 
lower amount of toxic metals coupled with the 
lack of CO emission by electronic cigarettes de-
creases the cardiovascular risk.
In marked contrast to classic cigarette use, 
there were no documented cases of cancer deve-
lopment in humans due to e-cigarette use. Ho-
wever, animal-based research indicated possible 
carcinogenesis as a result of aerosol exposure. 
Therefore, a practitioner who treats patients with 
a positive history of using electronic cigarettes 
needs to remain oncologically alert. A convincing 
argument in favour of exchanging traditional 
cigarettes for vaporizers is their less harmful, if 
any, influence on “passive smokers” — aerosols 
do not contain confirmed carcinogens, whereas 
tobacco smoke is a rich source of them.
Currently, there is no sufficient evidence con-
firming the superiority of using e-cigarettes over 
traditional cigarettes in relation to oral cavity di-
sease prevention. Serious afflictions caused by to-
bacco smoke, such as precancerous conditions or 
squamous cell carcinoma, were not convincingly 
associated with exposure to e-liquid aerosols. Pa-
tients undergoing dental care may potentially 
benefit from an exchange of classic cigarettes for 
electronic devices. However, it should be noted 
that the sweet aromas contained in liquids cause 
more frequently observed occurrences of decay, 
hence they should be avoided.
E-cigarettes are confirmed to be an effective 
way of fighting nicotine addiction. They have 
a greater efficacy in comparison with a single NRT 
according to studies from recent years published 
in prestigious periodicals (Nature, The Lancet). In 
the process of combating the addiction, electronic 
cigarette use also decreases the intensity of unple-
asant feelings associated with withdrawal from 
nicotine, which results in fewer treated patients 
who terminate the therapy prematurely. Moreover, 
social functioning is relatively easier for those in-
dividuals who use vaporizers during their combat 
with nicotine addiction because of their lower 
irritability and fatigue, unlike among smokers.
A significant hazard associated with e-ciga-
rette use is the phenomenon of dual smoking. Not 
only can it cause the summation of negative effects 
of both of these stimulants, but also increases the 
addiction to nicotine and can render the potential 
future fight with the addiction to be more difficult. 
This problem is fairly common, hence every prac-
titioner in contact with a vaping person should 
evaluate it on an ongoing basis. It is absolutely 
vital for dual smokers to gradually limit smoking 
traditional cigarettes. It allows for early substantial 
benefits to the circulatory system and additionally 
facilitates reduction of nicotine intake.
The substitution of classic cigarettes for 
e-cigarettes also provides for practical financial 
benefit. The statistical analyses of average selling 
prices indicate that refillable e-cigarettes are less 
expensive than traditional cigarettes. Obviously, 
every person deciding to exchange classic cigaret-
tes for electronic devices should be aware of the 
initial expense. However, in terms of Polish costs, 
an initial financial burden is recovered after only 
a few days and vaping becomes more affordable 
in the long-term.
Presently, it is crucial to investigate the 
connection between both methods of nicotine 
intake and the probability of the occurrence of 
coronavirus disease (COVID-19), as well as its 
severity. It was proven that both smoking and 
vaping increase the chance of infection, although 
traditional smokers may be at a higher risk. As of 
now, there is an insufficient number of compre-
hensive studies which would uniquely determine 
if exposure to e-liquid aerosol (versus exposure 
to tobacco smoke) increases the gravity of the 
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infectious process. The general awareness of the 
negative influence of e-cigarettes on the respira-
tory system seems to be sufficient to serve as an 
alert to individuals who vape and have a positive 
test result for SARS-CoV-2 infection. 
Despite the advantages of e-cigarettes over 
classic cigarettes in many aspects, the e-cigarette 
phenomenon poses a whole new kind of threat to 
public health. As shown by large meta-analyses 
based on studies of young adults and adolescents 
aged 14-30, the odds ratio for the subsequent 
smoking of classic cigarettes between previous 
users of e-cigarettes and individuals who never 
used them is as high as 3.50 [80]. This indicates 
the high addictive potential of e-cigarettes among 
young people who, through these devices, begin 
their tobacco addiction at an early age and go on 
to use classic cigarettes.
It should be noted that more research is re-
quired in order to study the potential influence 
of e-cigarettes on human carcinogenesis as well 
as the potential association of vaping with the 
onset of COPD. Currently, no evidence exists 
regarding the safe use of e-cigarettes by pregnant 
women, therefore complete cessation of smoking 
and vaping is to be advised. 
Conclusions
It should be acknowledged that despite the 
primary branding of e-cigarettes as a safer alter-
native to traditional cigarettes, this product is not 
devoid of negative impacts on the user’s health. 
For this reason, they cannot be advised, especially 
to pregnant women. Despite present restrictions 
in their use, there is a range of indications for 
the replacement of classic cigarettes with elec-
tronic ones with well-documented benefits for 
the patient. The beneficiaries mainly include 
predominantly smoking individuals who are be-
ing treated for arterial hypertension or asthma, 
as well as smokers who want to minimize the 
harmful influence of passive smoking on their 
environment. The application of e-cigarettes is 
worth considering in patients who wish to perma-
nently overcome their nicotine addiction. It may 
be especially recommended if previous trials of 
quitting smoking with a single NRT were ineffec-
tive. Due to the more frequently observed tobacco 
addiction among young people as a result of the 
use of e-cigarettes, this phenomenon should be 
perceived as a new threat to public health world-
wide. In view of this threat, appropriate legal 
regulations limiting access to such devices and 
information campaigns on the harms of tobacco 
addiction should be implemented. Apart from the 
therapeutic implications mentioned above, elec-
tronic cigarettes may have other properties which 
should be a focus of study in the near future. In 
conclusion, a medical practitioner should track 
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